NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

Phase 4

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: XR-B (SUBLOCADETM)
Drug: XR-NTX

First Posted Date: 2020-01-07

Last Posted Date: 2025-05-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 675

Registration Number: NCT04219540

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
Friends Research Institute, Baltimore, Maryland, United States
🇺🇸
Dartmouth College, Hanover, New Hampshire, United States

and more 3 locations

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Not Applicable

Completed

Conditions: Opioid-use Disorder

Interventions: Behavioral: PCP brief advice
Behavioral: Video doctor
Behavioral: Telephone health coaching
Behavioral: Nurse Care Manager (NCM) intervention

First Posted Date: 2020-01-06

Last Posted Date: 2025-02-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 321

Registration Number: NCT04218201

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS

Not Applicable

Completed

Conditions: Nicotine Addiction

Interventions: Other: Nicotine patch and gum
Behavioral: Minnesota Nicotine Withdrawal Scale (MNWS)
Behavioral: ASSIST (the Alcohol, Smoking and Substance Involvement Screening)
Behavioral: Counseling
Other: NIDA Standardized Research E-cigarettes (SREC)

First Posted Date: 2020-01-06

Last Posted Date: 2024-12-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 64

Registration Number: NCT04218708

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Project ACTIVE a Clinical Intervention

Not Applicable

Completed

Conditions: Alcohol Abuse
Obesity

Interventions: Behavioral: ACTIVE intervention

First Posted Date: 2019-12-26

Last Posted Date: 2020-01-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 140

Registration Number: NCT04211883

High Dose Oxytocin Nasal Spray for Treatment of Tinnitus

Phase 3

Terminated

Conditions: Tinnitus

Interventions: Other: Placebo nasal spray
Drug: Oxytocin

First Posted Date: 2019-12-24

Last Posted Date: 2022-10-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 33

Registration Number: NCT04210310

Locations: 🇺🇸
222 East 41st Street Ambulatory Care Center, Preston Robert Tisch Center for Men's Health, New York, New York, United States

Oral Nutritional Optimization in Total Joint Arthroplasty

Not Applicable

Recruiting

Conditions: Osteoarthritis

Interventions: Dietary Supplement: Ensure

First Posted Date: 2019-12-24

Last Posted Date: 2024-10-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 372

Registration Number: NCT04210284

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Rothman Orthopedic Institute, Philadelphia, Pennsylvania, United States

Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites

Not Applicable

Completed

Conditions: Sexually Transmitted Infection
Hiv

Interventions: Behavioral: SNAPS intervention

First Posted Date: 2019-12-20

Last Posted Date: 2023-02-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 200

Registration Number: NCT04207151

Locations: 🇺🇸
NYU Langone, New York, New York, United States

Testing the Decoy Effect to Increase Tobacco Treatment Uptake

Completed

Conditions: Tobacco Smoking

Interventions: Other: Online survey

First Posted Date: 2019-12-16

Last Posted Date: 2023-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 600

Registration Number: NCT04200157

Locations: 🇺🇸
NYU Langone Health - Translational Research Building, New York, New York, United States

Application of Forward-looking Infrared for the Identification and Evaluation of Fractures in the Acute Trauma Setting

Not Applicable

Withdrawn

Conditions: Acute Fracture

Interventions: Behavioral: FLIR E95 camera

First Posted Date: 2019-12-13

Last Posted Date: 2021-10-11

Lead Sponsor: NYU Langone Health

Registration Number: NCT04197505

Estrogen and Fear in PTSD

Phase 3

Completed

Conditions: PTSD

Interventions: Drug: Estradiol
Drug: Placebo oral tablet
Behavioral: Prolonged Exposure (PE) therapy

First Posted Date: 2019-12-10

Last Posted Date: 2025-04-10

Lead Sponsor: The University of Texas Health Science Center, Houston

Target Recruit Count: 64

Registration Number: NCT04192266

Locations: 🇺🇸
The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, United States
🇺🇸
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy